1101 related articles for article (PubMed ID: 26756400)
1. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
[TBL] [Abstract][Full Text] [Related]
2. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
[TBL] [Abstract][Full Text] [Related]
3. Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity.
Butzlaff M; Hannan SB; Karsten P; Lenz S; Ng J; Voßfeldt H; Prüßing K; Pflanz R; Schulz JB; Rasse T; Voigt A
Hum Mol Genet; 2015 Jul; 24(13):3623-37. PubMed ID: 25794683
[TBL] [Abstract][Full Text] [Related]
4. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
6. Transgenic animal models of tauopathies.
Lee VM; Kenyon TK; Trojanowski JQ
Biochim Biophys Acta; 2005 Jan; 1739(2-3):251-9. PubMed ID: 15615643
[TBL] [Abstract][Full Text] [Related]
7. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
[TBL] [Abstract][Full Text] [Related]
8. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation.
Chanu SI; Sarkar S
Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837
[TBL] [Abstract][Full Text] [Related]
9. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations
Bardai FH; Wang L; Mutreja Y; Yenjerla M; Gamblin TC; Feany MB
J Neurosci; 2018 Jan; 38(1):108-119. PubMed ID: 29138281
[TBL] [Abstract][Full Text] [Related]
10. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
Brandt R; Hundelt M; Shahani N
Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans.
Kraemer BC; Burgess JK; Chen JH; Thomas JH; Schellenberg GD
Hum Mol Genet; 2006 May; 15(9):1483-96. PubMed ID: 16600994
[TBL] [Abstract][Full Text] [Related]
12. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
13. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
[TBL] [Abstract][Full Text] [Related]
14. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
[TBL] [Abstract][Full Text] [Related]
16. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
17. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
18. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
19. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
20. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
Morelli F; Romeo M; Barzago MM; Bolis M; Mattioni D; Rossi G; Tagliavini F; Bastone A; Salmona M; Diomede L
Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]